Corti, D., & Kearns, J. D. (2016). Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease. Curr Opin Immunol.
Chicago ZitierstilCorti, Davide, und Jeffrey D. Kearns. "Promises and Pitfalls for Recombinant Oligoclonal Antibodies-based Therapeutics in Cancer and Infectious Disease." Curr Opin Immunol 2016.
MLA ZitierstilCorti, Davide, und Jeffrey D. Kearns. "Promises and Pitfalls for Recombinant Oligoclonal Antibodies-based Therapeutics in Cancer and Infectious Disease." Curr Opin Immunol 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.